Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2012-10-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第四届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2012 third quarter report. It states that the Supervisory Board reviewed and approved the quarterly report and confirms the report's compliance and accuracy. The document is short (595 characters) and primarily announces the approval of the quarterly report rather than containing the full financial data or detailed analysis itself. Therefore, it is not the quarterly report (IR) itself but an announcement related to it. Given the nature of the content, it fits best under Regulatory Filings (RNS) as a formal announcement of the Supervisory Board's resolution and approval of the quarterly report.
2012-10-25 Chinese
第四届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 嘉事堂药业股份有限公司 dated October 23, 2012. It reports the approval of the company's 2012 third quarter report and its summary by the board of directors. The document is short (491 characters) and primarily announces the board's decision rather than containing the full quarterly report or detailed financial data. Therefore, it is not the interim/quarterly report itself but a board/management information announcement regarding the approval of that report.
2012-10-25 Chinese
关于2012年三季度报告的更正公告
Regulatory Filings Classification · 95% confidence The document is titled as a correction announcement regarding the 2012 third quarter report of the company 嘉事堂药业股份有限公司. It specifically corrects previously disclosed financial data such as earnings per share and net profit figures for the third quarter and the first nine months of 2012. The document is relatively short (2814 characters) and focuses on correcting previously published quarterly financial data rather than presenting a full quarterly report. It references the original quarterly report and states that the corrected full text and main text are available on the disclosure website. This indicates that the document is an announcement correcting a previously released interim/quarterly report rather than the report itself. According to the rules, such a correction announcement is best classified under Regulatory Filings (RNS) because it is a regulatory announcement correcting financial data, not the full interim report itself.
2012-10-25 Chinese
2012年第三季度报告正文（已取消）
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2012 Third Quarter Report Summary" of 嘉事堂药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net profit, cash flow, earnings per share, and explanations of significant changes in financial statement items compared to previous periods. It also includes management's discussion on performance, shareholder information, and forecasts for the full year 2012. The length of the document (8093 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2012
2012-10-25 Chinese
2012年第三季度报告正文（更新后）
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2012 Third Quarter Report Summary" and contains detailed financial data including total assets, net profit, earnings per share, cash flow, and other financial indicators for the third quarter of 2012. It also includes management's explanations for significant changes in financial statement items, shareholder information, and performance forecasts for the year 2012. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) indicates this is an Interim / Quarterly Report. The document length (8018 characters) and detailed financial content confirm it is the report itself, not just an announcement or summary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2012
2012-10-25 Chinese
四届一次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of 嘉事堂药业股份有限公司 regarding the election of the Supervisory Board Chairman and the approval of the 2012 semi-annual report. It includes details about the meeting, voting results, and a statement confirming the accuracy and completeness of the half-year report prepared by the Board of Directors. The document does not contain the actual financial statements or detailed financial data of the semi-annual report but rather the Supervisory Board's approval and confirmation of the report's compliance. The document length is short (1092 characters), and it serves as an official announcement of the Supervisory Board's resolution and approval rather than the report itself. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement related to corporate governance and report approval but does not contain the full interim report or detailed financial data.
2012-08-18 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.